CN104013909A - Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis - Google Patents
Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis Download PDFInfo
- Publication number
- CN104013909A CN104013909A CN201410205111.6A CN201410205111A CN104013909A CN 104013909 A CN104013909 A CN 104013909A CN 201410205111 A CN201410205111 A CN 201410205111A CN 104013909 A CN104013909 A CN 104013909A
- Authority
- CN
- China
- Prior art keywords
- component
- chinese medicine
- traditional chinese
- lower limb
- filariasis
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 239000003814 drug Substances 0.000 title claims abstract description 20
- 210000003141 lower extremity Anatomy 0.000 title claims abstract description 12
- 201000006353 Filariasis Diseases 0.000 title abstract description 7
- 241000244005 Wuchereria bancrofti Species 0.000 title abstract 3
- 208000006036 elephantiasis Diseases 0.000 title abstract 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 14
- 241000255789 Bombyx mori Species 0.000 claims abstract description 11
- 244000024893 Amaranthus tricolor Species 0.000 claims description 14
- 235000014748 Amaranthus tricolor Nutrition 0.000 claims description 14
- 239000003664 filaricide agent Substances 0.000 claims description 12
- 235000004360 Dioscorea zingiberensis Nutrition 0.000 claims description 10
- 241001678283 Dioscorea zingiberensis Species 0.000 claims description 10
- 241001604597 Pyrestini Species 0.000 claims description 10
- 244000061458 Solanum melongena Species 0.000 claims description 10
- 230000000694 effects Effects 0.000 abstract description 6
- 238000002360 preparation method Methods 0.000 abstract description 4
- 240000005748 Achyranthes aspera Species 0.000 abstract 1
- 235000005517 Achyranthes aspera Nutrition 0.000 abstract 1
- 240000001592 Amaranthus caudatus Species 0.000 abstract 1
- 235000009328 Amaranthus caudatus Nutrition 0.000 abstract 1
- 235000015363 Amaranthus cruentus Nutrition 0.000 abstract 1
- 235000013478 Amaranthus oleraceus Nutrition 0.000 abstract 1
- 241001226187 Cyrtomium fortunei Species 0.000 abstract 1
- 244000223060 Erythrina herbacea Species 0.000 abstract 1
- 235000005280 Erythrina herbacea Nutrition 0.000 abstract 1
- 241001330502 Stephania Species 0.000 abstract 1
- 235000007212 Verbena X moechina Moldenke Nutrition 0.000 abstract 1
- 240000001519 Verbena officinalis Species 0.000 abstract 1
- 235000001594 Verbena polystachya Kunth Nutrition 0.000 abstract 1
- 235000007200 Verbena x perriana Moldenke Nutrition 0.000 abstract 1
- 235000002270 Verbena x stuprosa Moldenke Nutrition 0.000 abstract 1
- 239000008280 blood Substances 0.000 description 8
- 210000004369 blood Anatomy 0.000 description 8
- 206010040943 Skin Ulcer Diseases 0.000 description 2
- 238000009835 boiling Methods 0.000 description 2
- 230000003203 everyday effect Effects 0.000 description 2
- 235000011389 fruit/vegetable juice Nutrition 0.000 description 2
- 208000006750 hematuria Diseases 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 244000045947 parasite Species 0.000 description 2
- 231100000019 skin ulcer Toxicity 0.000 description 2
- 231100000331 toxic Toxicity 0.000 description 2
- 230000002588 toxic effect Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 206010003399 Arthropod bite Diseases 0.000 description 1
- 206010009168 Chyluria Diseases 0.000 description 1
- 201000000297 Erysipelas Diseases 0.000 description 1
- 208000000616 Hemoptysis Diseases 0.000 description 1
- 208000032843 Hemorrhage Diseases 0.000 description 1
- 206010027336 Menstruation delayed Diseases 0.000 description 1
- 208000030852 Parasitic disease Diseases 0.000 description 1
- 208000018525 Postpartum Hemorrhage Diseases 0.000 description 1
- 206010037660 Pyrexia Diseases 0.000 description 1
- 208000027418 Wounds and injury Diseases 0.000 description 1
- 206010000210 abortion Diseases 0.000 description 1
- 231100000176 abortion Toxicity 0.000 description 1
- 230000009286 beneficial effect Effects 0.000 description 1
- 230000017531 blood circulation Effects 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 201000010099 disease Diseases 0.000 description 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
- 208000001848 dysentery Diseases 0.000 description 1
- 238000005516 engineering process Methods 0.000 description 1
- 208000001780 epistaxis Diseases 0.000 description 1
- 230000035876 healing Effects 0.000 description 1
- 208000035861 hematochezia Diseases 0.000 description 1
- 230000023597 hemostasis Effects 0.000 description 1
- 208000015181 infectious disease Diseases 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 201000003265 lymphadenitis Diseases 0.000 description 1
- 206010025226 lymphangitis Diseases 0.000 description 1
- 210000001365 lymphatic vessel Anatomy 0.000 description 1
- 210000003563 lymphoid tissue Anatomy 0.000 description 1
- 208000007106 menorrhagia Diseases 0.000 description 1
- 230000000414 obstructive effect Effects 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 231100000614 poison Toxicity 0.000 description 1
- 208000037920 primary disease Diseases 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- 238000000197 pyrolysis Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 208000004441 taeniasis Diseases 0.000 description 1
- 230000001225 therapeutic effect Effects 0.000 description 1
- 239000003440 toxic substance Substances 0.000 description 1
- 208000019206 urinary tract infection Diseases 0.000 description 1
- 239000002699 waste material Substances 0.000 description 1
Landscapes
- Medicines Containing Plant Substances (AREA)
Abstract
The invention relates to a traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis. The traditional Chinese medicine comprises a component A and a component B, wherein the component A consists of purple amaranth and water; the component B consists of stephania terandra, bark of himalayan coralbean, Rhizoma Wenyujin concisa, silkworm excrement, rhizoma atractylodis, cyrtomium fortunei, achyranthes aspera and verbena. The traditional Chinese medicine has a good curative effect on lower limb elephantiasis caused by filariasis, the cure rate can be 98.5 percent, the cure rate is obviously increased, and the traditional Chinese medicine uses a pure traditional Chinese medicine preparation, does not have side effects on the body and is widely suitable for the crowd.
Description
Technical field
The present invention relates to a kind of Chinese medicine, be specifically related to a kind of Chinese medicine for the treatment of the lower limb elephatiasis that filaricide causes.
Background technology
Filaricide is to parasitize the parasitic disease due to lymphoid tissue, subcutaneous tissue or film chamber by filaricide.Domestic popular be Filariasis.Clinical manifestation is lymphangitis and lymphadenitis in early days, occurs lymphatic vessel obstructive symptom and lower limb elephatiasis late period.In blood, having patient or the carrier of microfilariae of ohchocerciasis is the main source of infection, through mosquito bite, propagate, and the general susceptible of crowd, primary disease belongs to the traditional Chinese medical science " erysipelas ", " big foot wind ", " stranguria marked by chyluria " category.Before the applicant, applied for the application for a patent for invention that application number is 201110159199.9, invented a kind of Chinese medicine for the treatment of filaricide, through Long-term clinical test, found, the Chinese medicine of above-mentioned application is only effective to some patients were, although can effectively suppress PD, cure rate is lower.
goal of the invention
The object of this invention is to provide a kind of Chinese medicine for the treatment of the lower limb elephatiasis that filaricide causes, on original basis, Chinese medicine ingredients is improved, improved cure rate.
The present invention is achieved through the following technical solutions:
A Chinese medicine for the treatment of the lower limb elephatiasis that filaricide causes, comprises component A and component B, and described component A is comprised of aubergine Amaranthus mangostanus L. and water, and the weight ratio of described aubergine Amaranthus mangostanus L. and water is 1:1.5-6; Component B is comprised of Radix Stephaniae Tetrandrae, Cortex erythrinae, sheet Dioscorea zingiberensis, Bombyx mori L., Rhizoma Atractylodis, Rhizoma Osmundae, Radix Achyranthis, Herba Verbenae, and the weight of each component is Radix Stephaniae Tetrandrae 2.5-3.5g, Cortex erythrinae 2.5-3.5g, sheet Dioscorea zingiberensis 2.5-3.5g, Bombyx mori L. 2.5-3.5g, Rhizoma Atractylodis 1.5-2.5g, Rhizoma Osmundae 3.5-5.5g, Radix Achyranthis 2.5-3.5g, Herba Verbenae 3.5-5.5g.
Aubergine Amaranthus mangostanus L. is cleaned, then added appropriate water, boil, boiling 1-4min, pulls Amaranthus mangostanus L. out, obtains component A, and juice is packed in kettle, is used as boiled water and drinks, and do not limit number of times every day, there is no toxic and side effects, and component A is the main auxiliary element for the treatment of.
Radix Stephaniae Tetrandrae 2.5-3.5g, Cortex erythrinae 2.5-3.5g, sheet Dioscorea zingiberensis 2.5-3.5g, Bombyx mori L. 2.5-3.5g, Rhizoma Atractylodis 1.5-2.5g, Rhizoma Osmundae 3.5-5.5g, Radix Achyranthis 2.5-3.5g, Herba Verbenae 3.5-5.5g are added to appropriate decocting, 0.5h is decocted in big fire, use little fire instead, continue to decoct 1h, obtain component B.Wherein component A and component B are used alternatingly every other day, take 3 months, and the cure rate of the lower limb elephatiasis that filaricide is caused reaches 98.5%, for the lighter patient of disease, take medicine and can fully recover for 20 days.
Rhizoma Osmundae function cures mainly heat-clearing and toxic substances removing, hemostasis, parasite killing.For cold, fever, dysentery, damp and hot, skin infection, has blood in stool, hematuria, and menorrhagia, knife injury is hemorrhage, ascarid, rich worm, filariid, taeniasis, artificial abortion, postpartum hemorrhage.
Radix Achyranthis blood circulation promoting and blood stasis dispelling, removing damp-heat, controls hemoptysis, epistaxis, hematuria, urinary tract infection, humid tropics is inferior.
< < Bencao Jingshu > >: Herba Verbenae is originally the medicine of removing heat from blood removing blood stasis.Bottom NI skin ulcer person, the utmost point of heat in blood, furthermore damp and hot, thus the turbid skin ulcer that forms of blood stains, and have worm also.The cool pyrolysis of blood, the broken and row of dirty person, waste and be not recovered.CHEN Zang-Qi is called its removing blood stasis parasite killing, also this meaning ear.
The present invention adds Rhizoma Osmundae, Radix Achyranthis, the three-dimensional Chinese medicine of Herba Verbenae on the basis of original application, has greatly improved the therapeutic effect to filaricide, has improved cure rate.
Beneficial effect of the present invention: the lower limb elephatiasis that Chinese medicine of the present invention causes filaricide has good curative effect, and cure rate can reach 98.5%, and cure rate obviously improves, and non-relapse after healing, use pure Chinese medicinal preparation simultaneously, health is free from side effects, applicable crowd is extensive.
The specific embodiment
A Chinese medicine for the treatment of the lower limb elephatiasis that filaricide causes, comprises component A and component B, and described component A is comprised of aubergine Amaranthus mangostanus L. and water, and the weight ratio of described aubergine Amaranthus mangostanus L. and water is 1:1.5-6; Component B is comprised of Radix Stephaniae Tetrandrae, Cortex erythrinae, sheet Dioscorea zingiberensis, Bombyx mori L., Rhizoma Atractylodis, Rhizoma Osmundae, Radix Achyranthis, Herba Verbenae, and the weight of each component is Radix Stephaniae Tetrandrae 2.5-3.5g, Cortex erythrinae 2.5-3.5g, sheet Dioscorea zingiberensis 2.5-3.5g, Bombyx mori L. 2.5-3.5g, Rhizoma Atractylodis 1.5-2.5g, Rhizoma Osmundae 3.5-5.5g, Radix Achyranthis 2.5-3.5g, Herba Verbenae 3.5-5.5g.
Aubergine Amaranthus mangostanus L. is cleaned, then added appropriate water, boil, boiling 1-4min, pulls Amaranthus mangostanus L. out, obtains component A, and juice is packed in kettle, is used as boiled water and drinks, and do not limit number of times every day, there is no toxic and side effects, and component A is the main auxiliary element for the treatment of.
Radix Stephaniae Tetrandrae 2.5-3.5g, Cortex erythrinae 2.5-3.5g, sheet Dioscorea zingiberensis 2.5-3.5g, Bombyx mori L. 2.5-3.5g, Rhizoma Atractylodis 1.5-2.5g, Rhizoma Osmundae 3.5-5.5g, Radix Achyranthis 2.5-3.5g, Herba Verbenae 3.5-5.5g are added to appropriate decocting, 0.5h is decocted in big fire, use little fire instead, continue to decoct 1h, obtain component B.Wherein component A and component B are used alternatingly every other day, take 3 months, and cure rate reaches more than 98%.
Embodiment 2
Component A
1 jin of aubergine Amaranthus mangostanus L., 3 jin, water;
Component B
Radix Stephaniae Tetrandrae 3g, Cortex erythrinae 2.5g, sheet Dioscorea zingiberensis 2.5g, Bombyx mori L. 3g, Rhizoma Atractylodis 2.5g, Rhizoma Osmundae 3.5g, Radix Achyranthis 3g, Herba Verbenae 4g; Use the method preparation of embodiment 1.
Cao Minran, man, 72 years old, suffer from filaricide 35 years, two lower limb elephatiasis, cause both legs handicapped, take this medicine, and component A and component B alternately take 1 month, and lower limb elephatiasis symptom is clearly better, and after two first quarter moons, fully recovers.
Embodiment 3
Component A
2 jin of aubergine Amaranthus mangostanus L.s, 4 jin, water boils Amaranthus mangostanus L. 4 minutes in water, pulls Amaranthus mangostanus L. out, obtains component A;
Component B
Radix Stephaniae Tetrandrae 3.5g, Cortex erythrinae 3.2g, sheet Dioscorea zingiberensis 2.8g, Bombyx mori L. 3.5g, Rhizoma Atractylodis 2g, Rhizoma Osmundae 3.8g, Radix Achyranthis 2.8g, Herba Verbenae 4.5g, used the method preparation described in embodiment 1.
Su Yuxiang, man, 75 years old, suffer from filaricide 25 years, two lower limb elephatiasis, are used the recovery from illness in 2 months of this medicine.
Zhou Shufang, female, 67 years old, suffer from filaricide 18 years, two lower limb elephatiasis, are used this medicine to fully recover after 2 months.
Zhang Shiqin, female, 63 years old, change-blood filaricide 15 years, two lower limb elephatiasis, are used the recovery from illness in 25 days of this medicine.
Claims (1)
1. a Chinese medicine for the treatment of the lower limb elephatiasis that filaricide causes, is characterized in that: comprise component A and component B, described component A is comprised of aubergine Amaranthus mangostanus L. and water, and the weight ratio of described aubergine Amaranthus mangostanus L. and water is 1:1.5-6; Component B is by Radix Stephaniae Tetrandrae, Cortex erythrinae, sheet Dioscorea zingiberensis, Bombyx mori L., Rhizoma Atractylodis, Rhizoma Osmundae, Radix Achyranthis, Herba Verbenae, and the weight of each component is Radix Stephaniae Tetrandrae 2.5-3.5g, Cortex erythrinae 2.5-3.5g, sheet Dioscorea zingiberensis 2.5-3.5g, Bombyx mori L. 2.5-3.5g, Rhizoma Atractylodis 1.5-2.5g, Rhizoma Osmundae 3.5-5.5g, Radix Achyranthis 2.5-3.5g, Herba Verbenae 3.5-5.5g.
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410205111.6A CN104013909A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201410205111.6A CN104013909A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN104013909A true CN104013909A (en) | 2014-09-03 |
Family
ID=51431090
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201410205111.6A Pending CN104013909A (en) | 2014-05-15 | 2014-05-15 | Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN104013909A (en) |
-
2014
- 2014-05-15 CN CN201410205111.6A patent/CN104013909A/en active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| CN101411808B (en) | Method for preparing Chinese medicine for treating heat intestine and stomach type constipation | |
| CN106491769A (en) | The Traditional Chinese medicine compound gel agent for the treatment of wound, preparation method and applications | |
| CN105641564A (en) | Medicine for treating gouty arthritis by combining oral administration and external application of traditional Chinese medicines | |
| CN103638502A (en) | Medicament for treating behcet disease and preparation method of medicament | |
| CN104587219A (en) | Traditional Chinese medicine for treating functional uterine bleeding | |
| CN102716212B (en) | Medicine for treating cerebral infarction | |
| CN104013909A (en) | Traditional Chinese medicine for treating lower limb elephantiasis caused by filariasis | |
| CN106109925A (en) | A kind of Chinese medicine decoction for treating constipation | |
| CN105412890A (en) | Traditional Chinese medicinal fumigating and washing solution for treating gonarthromeningitis, and preparation method thereof | |
| CN105727001A (en) | Traditional Chinese medicine composition for treating cardiovascular and cerebrovascular diseases | |
| CN104666799A (en) | Blood circulation activating and blood stasis removing medicinal liquor for soft tissue injury and preparation method of medicinal liqour | |
| CN105169034A (en) | Traditional Chinese medicine composition for treating hypertension and preparation method thereof | |
| CN104398774A (en) | Traditional Chinese drug for treating diabetic peripheral neuropathy | |
| CN103893480A (en) | Traditional Chinese medicine preparation for treating kidney deficiency and blood stasis type oviduct obstructive infertility | |
| CN102805824B (en) | Drug for curing apoplexy and preparation method thereof | |
| CN105055789A (en) | Traditional Chinese medicine fumigant for relieving pain of soft tissue injury and preparation method thereof | |
| CN104922329A (en) | Traditional Chinese medicine for treating heart blood stagnation type palpitation disease | |
| CN104306586A (en) | Traditional Chinese medicine for treating chronic nephritis | |
| CN104225293A (en) | Traditional Chinese medicine disinfectant solution for clinical laboratory | |
| CN105267777A (en) | Medicine for treating periodontitis | |
| CN103127400B (en) | Drug for treatment of anxiety disorder and preparation method thereof | |
| CN103285177A (en) | Externally used paste for treating bedsore and furuncle | |
| CN104740516A (en) | Traditional Chinese medicine for treating coronary heart disease | |
| CN104474058A (en) | Traditional Chinese medicine liquor for mainly treating traumatic injury and preparation method of traditional Chinese medicine liquor | |
| CN105079522A (en) | Medicine for treating chronic prostatitis |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20140903 |